{
    "Trade/Device Name(s)": [
        "hema-screen\u2122 SPECIFIC Gold"
    ],
    "Submitter Information": "Immunostics, Inc.",
    "510(k) Number": "K171484",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060463"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHE"
    ],
    "Summary Letter Date": "May 19, 2017",
    "Summary Letter Received Date": "May 22, 2017",
    "Submission Date": "May 19, 2017",
    "Regulation Number(s)": [
        "21 CFR 864.6550"
    ],
    "Regulation Name(s)": [
        "Occult blood test"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Human hemoglobin"
    ],
    "Specimen Type(s)": [
        "Feces"
    ],
    "Specimen Container(s)": [
        "DEVEL-A-TAB Sampler",
        "Specimen preparation tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Test cassette detection system"
    ],
    "Method(s)/Technology(ies)": [
        "Sandwich dye conjugate immunoassay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cassette",
        "Specimen collection device",
        "Buffer",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for hema-screen\u2122 SPECIFIC Gold fecal occult blood immunoassay utilizing monoclonal and polyclonal antibodies to detect human hemoglobin in feces",
    "Indications for Use Summary": "Rapid qualitative determination of human blood in fecal samples to aid in detection of gastrointestinal bleeding and disorders such as diverticulitis, colitis, polyps, and colorectal cancer for professional and laboratory use",
    "fda_folder": "Hematology"
}